文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

皮肤科诊断的慢性炎症性皮肤病患者静脉血栓栓塞发生率

Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases.
PubMed 文献 · JAMA Dermatol · 2021-01-01

经倾向评分匹配后,银屑病、特应性皮炎、斑秃、白癜风、化脓性汗腺炎及整体CISD的VTE风险均未显著升高。

要点

  • 皮肤科诊断的CISD患者VTE发生率与无CISD者相比无显著增加。
  • 银屑病匹配后VTE风险比0.86(95%CI 0.75-0.99),不支持风险升高。
  • 化脓性汗腺炎风险比1.64(95%CI 0.82-3.27),置信区间宽,需谨慎解读。

核心结论

  • 在控制相关VTE危险因素后,慢性炎症性皮肤病患者未显示VTE发生率增加。

主要发现

  • CISD患者中位随访1.9年(IQR 0.8-4.0),VTE总发生率为1.53/1000人年,无CISD者为1.76/1000人年。
  • 各病种VTE发生率(每1000人年):银屑病1.57、特应性皮炎1.83、斑秃0.94、白癜风0.93、化脓性汗腺炎1.65。
  • 倾向评分匹配后VTE风险比:银屑病0.86(95%CI 0.75-0.99)、特应性皮炎1.19(95%CI 0.95-1.48)、斑秃0.97(95%CI 0.65-1.46)、白癜风0.90(95%CI 0.49-1.65)、化脓性汗腺炎1.64(95%CI 0.82-3.27)、CISD整体0.94(95%CI 0.84-1.05)。

临床怎么用

  • 对于皮肤科诊断的CISD患者,无需仅因疾病本身而常规筛查或预防VTE。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Several studies have linked chronic inflammatory skin diseases (CISDs) with venous thromboembolism (VTE) in a range of data sources with mixed conclusions. OBJECTIVE: To examine the incidence of VTE in patients with vs without CISD. DESIGN, SETTING, AND PARTICIPANTS: A cohort study using commercial insurance claims data from a nationwide US health care database from January 1, 2004, through 2019 was conducted. A total of 158 123 patients with dermatologist-recorded psoriasis, atopic dermatitis, alopecia areata, vitiligo, or hidradenitis suppurativa were included. Risk-set sampling identified patients without a CISD. Patient follow-up lasted until the first of the following occurred: VTE, death, disenrollment, or end of data stream. EXPOSURES: Patients with vs without CISD. MAIN OUTCOMES AND MEASURES: Venous thromboembolism events were identified with validated algorithms. Incidence rates were computed before and after 1:1 propensity-score matching to account for VTE risk factors. Hazard ratios were estimated to compare the incidence of VTE in the CISD vs non-CISD cohorts. RESULTS: A total of 158 123 patients were identified with CISD: with psoriasis (n = 96 138), atopic dermatitis (n = 30 418), alopecia areata (n = 17 889), vitiligo (n = 7735), or HS (n = 5934); 9 patients had 2 of these conditions. A total of 1 570 387 patients were without a CISD. The median follow-up time was 1.9 years (interquartile range, 0.8-4.0 years) in patients with CISD. The incidence rate (per 1000 person-years) of outpatient or inpatient VTE was 1.57 in psoriasis, 1.83 in atopic dermatitis, 0.94 in alopecia areata, 0.93 in vitiligo, 1.65 in HS and 1.53 in CISD overall, compared with 1.76 in patients without a CISD. Incidence rates increased in patients aged 50 years or older (2.3 per 1000 person-years) and decreased in those aged 18 to 49 years (0.8 per 1000 person-years). After propensity-score matching to patients without a CISD, the hazard ratio (HR) of VTE was 0.86 (95% CI, 0.75-0.99) in psoriasis, 1.19 (95% CI, 0.95-1.48) in atopic dermatitis, 0.97 (95% CI, 0.65-1.46) in alopecia areata, 0.90 (95% CI, 0.49-1.65) in vitiligo, 1.64 (95% CI, 0.82-3.27) in hidradenitis suppurativa, and 0.94 (95% CI, 0.84-1.05) in CISD overall. CONCLUSIONS AND RELEVANCE: In this large-scale cohort study, CISDs were not associated with an increased incidence of VTE after controlling for relevant VTE risk factors in a representative dermatology patient population.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Schneeweiss MC, Kim SC, Wyss R, et al. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021. PMID: 34037662. doi:10.1001/jamadermatol.2021.1570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。